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Prevention and controlBackground. The 5th Joint Task Force European guidelines on cardiovascular disease (CVD) prevention rec-
ommend the measurement of carotid intima-media thickness (CIMT) in asymptomatic individuals at moderate
risk (Class IIa). We aimed to evaluate the ability of CIMT to further risk stratify patients. Design. Cross-sectional
study. Methods. Patients aged over 18 years free of known CVD at moderate, high, or very high risk of CVD
were included. The Panasonic Cardiohealth station, a semi-automated ultrasound system, was used to detect ca-
rotid plaque andmeasure CIMT. Elevated CIMTwas deﬁned as=/N0.9mm.We analyzed the percentage of those
at moderate risk reclassiﬁed after addition of CIMT. Results. Two hundred patients were included (55% women,
mean age 57 years, 12% diabetic); 64%, 23% and 13%were classiﬁed asmoderate, high, and very high risk, respec-
tively. Across these risk categories, 17%, 33%, and 46% had elevated IMT, p for trend b0.001. With the addition of
CIMT, 13.9% (95% CI: 5.7% to 22.1%) of women and 20.4% (95% CI: 8.7% to 32.1%) of men initially moderate risk
were reclassiﬁed. Conclusions. CIMT measurement reclassiﬁes a considerable percentage of those at moderate
risk based on traditional risk factors alone.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Cardiovascular disease (CVD), which includes coronary heart dis-
ease, stroke, and peripheral vascular disease, is the most important
cause of death in the developed world. Rates of CVD in the develop-
ing world are rapidly increasing (The Global Burden of Disease,
2008). The atherosclerosis which causes CVD often develops early
in life and progresses insidiously. It may be advanced by the time
of presentation with clinical symptoms, and the ﬁrst presentation
may be a fatal myocardial infarction or highly disabling stroke. This
highlights the importance of a preventive strategy for CVD since
medical treatments, while effective, in these circumstances may be
either inapplicable or palliative (Graham et al., 2007). Two comple-
mentary approaches to CVD prevention are required. The population
strategy attempts to reduce the risk factor burden in the entire pop-
ulation, thereby reducing the incidence of disease (Rose, 1991). In
the high-risk strategy, asymptomatic individuals at an increased
risk of future development of CVD are identiﬁed and the most inten-
sive risk factor modiﬁcations are directed towards these individuals
as they will gain most (Graham et al., 2007; Perk et al., 2012).
At present, those at high risk are detected on the basis of the risk
caused by the combination of their risk factors. This is calculated usingnic, Old Lucan Road, Dublin 20,
. This is an open access article underrisk estimation systems, for example, SCORE (Systematic Coronary
Risk Evaluation) or Framingham (Conroy et al., 2003; McGorrian et al.,
2008). Another approach to detecting those at high risk is to look for
for the presence of subclinical atherosclerosis. Examples include com-
puterized tomography (CT) scanning for the presence of coronary calci-
um, which is indicative of the presence of coronary atherosclerosis, and
ultrasound scanning of the carotid vessels for the presence of athero-
sclerosis. Advantages of carotid scanning are that it is relatively inex-
pensive, non-invasive, and involves no exposure to radiation.
Carotid intima-media thickness (CIMT) and the presence of carotid
plaques are the twomost commonly used indices of carotid atherosclero-
sis. The CIMT is deﬁned as themeasurement of the thickness of the tunica
intima and the tunicamedia, the innermost two layers of the arterialwall.
Several prospective studies have shown the relationship between
CIMT and future development of CVD. In 15,792 healthy subjects aged
45–65 years in the Atherosclerosis Risk in Communities Study (ARIC)
whowere followed prospectively for 4–7 years, increased CIMTwas as-
sociatedwith increased risk of CHD, HR of 1.13 forMI per 0.1mmdiffer-
ence in CCA (common carotid artery) IMT, adjusted for age and gender
(Chambless et al., 1997). In the Rotterdam Study of 7,983 subjects, the
HR was 1.19 for the same measurement (Bots et al., 1997).
The 5th Joint Task Force (JTF) European guidelines on CVD pre-
vention recommend that the measurement of carotid intima-media
thickness and/or screening for atherosclerotic plaques by carotid ar-
tery scanning should be considered for cardiovascular risk assess-
ment in asymptomatic adults at moderate risk (Perk et al., 2012).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Box 1
Individuals eligible for inclusion in the study, subdivided by risk category
as defined by the 5th JTF European guidelines on CVD prevention.
Very high
risk
Subjects with any of the following:
• Diabetes (type 1 or type 2) with one other CV risk
factor or target organ damage
• Patients with to severe CKD (GFR b30 ml/min/
1.73 m2)
• SCORE≥ 10%
High risk Subjects with
• Diabetes (type 1 or type 2) without other CV risk
factors or target organ damage
• Patients with moderate CKD (GFR b60 ml/min/
1.73 m2)
•Markedly elevated single risk factors such as:
◦ Familial dyslipidemias
◦ Severe hypertension
• SCORE of≥5% and b10%
Moderate
risk
SCORE is≥1 and b5% at 10 years, further
modulated by
• Family history of premature CAD
• Abdominal obesity
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level of evidence B. The American (ACC/AHA) guidelines recommend
assessment for carotid atherosclerosis in the intermediate risk
group, with the same grade of recommendation and level of evidence
(Greenland et al., 2010).
The Cardiohealth Station is a newly developed automated onscreen
carotid ultrasonography device, which allows detection of carotid
plaques and automated measurement of carotid IM (http://
www.panasonic.com/business/medicalvideo/CardioHealth/, n.a.). The
measurements are made at the common carotid artery.
Our objective was to measure CIMT and to assess for the presence of
carotid plaques in asymptomatic patients attending a CVD risk clinic
and answer two key questions:
1. Does CIMT measurement and presence of carotid plaques relate to
total CV risk category as determined using clinical risk factors,
based on the new four categories of risk recommended by the 5th
European guidelines on CVD prevention?
2. What percentage of those atmoderate risk based on clinical factors is
reclassiﬁed to a high-risk category after the measurement of CIMT
and assessment for the presence of carotid plaques?
Methods
Study population
Patients attending the outpatient clinic at the Adelaide Meath
Hospital for assessment and management of cardiovascular disease
risk, without prior evidence of cardiovascular disease, were screened
for eligibility for inclusion in the study. Individuals with and without
diabetes were included. Patients aged 18 years or over were included
if they were categorized asmoderate, high, or very high-risk categories,
as deﬁned by the 5th JTF European guidelines on CVD prevention (see
Box 1). The main exclusion criterion was the presence of established
CVD. This was deﬁned as coronary disease, including previous revascu-
larization, acute coronary syndromeor stable angina, stroke or transient
ischemic attack, previously detected carotid disease, peripheral vascular
disease, or abdominal aortic aneurysm. Those who were unable to give
consent and pregnant women were also excluded. All eligible patients
attending the clinic were invited to participate. The enrolment period
was from November 2012 to February 2014.
Measurements
Using the Cardiohealth Station, threemeasurements of right and left
carotid intima-media thickness (CIMT) at the common carotid artery
were taken. Participants also had assessment for the presence of carotid
plaques bilaterally.
Other clinical measurements were undertaken on the day of investi-
gation, including blood pressure, heart rate, waist circumference, and
body mass index. The most recent available laboratory measurements,
including lipid measurements (total cholesterol, high-density lipopro-
tein cholesterol, low-density lipoprotein cholesterol, and triglycerides),
fasting glucose measurement, and cholesterol measurements were un-
dertaken using the enzymatic method. Information on other risk factors
was also obtained as part of the clinical history, including smoking sta-
tus, physical activity level, family history of premature CVD, and medi-
cation usage. Smoking status was based on self-report, and patients
were considered former smokers if they quit smoking greater than 6
months prior to the examination. Diabetic status was based on self-
report and review ofmedical chart andmedication list for a previous di-
agnosis of diabetes. Physical activity level was based on self-report of
physical activity category based on the European guideline deﬁnition.
Patients were asked “Would you undertake more, less of equal to the
following amount of physical activity: 2.5 to 5 h of moderately vigorous
physical activity weekly (Perk et al., 2012)? Using this information, theSCORE risk was calculated on all participants. SCORE (systematic coro-
nary risk valuation) estimates the 10-year risk of CVD mortality. Using
the combination of SCORE and other risk factors, all patients were
assigned to a risk category according to the recommendations of the
5th European guidelines on CVD prevention (see Box 1). The full data
collection sheet is included in the supplementary material.
Written consent was obtained from all participants. The investiga-
tors received ethics approval for this study through the Adelaide
Meath hospital ethics committee. All patient information, including per-
sonal identiﬁers, was stored on an excel spreadsheet in an encrypted
volume on a laptop hard disk. After the collection of all patient data
and once recruitment of patients was complete, patient identiﬁers
were removed, and the data were permanently anonymized.
Statistical analysis
All statistical analyses were completed using Stata version 9. The per-
centage in each risk category with elevated IMT in either the right or left
carotid artery was assessed. Additionally, the percentage with elevated
IMT on either side or the presence of plaque in either carotid artery was
assessed. Theχ2 test for trend (Stata's ptrend command)was used to assess
for statistical signiﬁcance of the differences in percentages across the
three groups. In all cases, elevated IMT was deﬁned as =/≥ 0.9 mm, as
per European guidelines (Perk et al., 2012).
The number of patients with elevated IMT demonstrated in either
the left or right carotid artery as a percentage of the total number in
themoderate risk category was calculated. The number with either ele-
vated IMT or presence of carotid plaque was also calculated. The 95%
conﬁdence intervals for these percentages were calculated. These pa-
tients were considered reclassiﬁed to a higher risk category through
the addition of the carotid measurements to their risk assessment.
Results
Cardiohealth station examinations were performed on 201 individ-
uals (54%women). Full data required for risk categorizationwas available
Table 2
Carotid intima-media thickness (mean and standard deviation) and carotid plaque inmen
and women.
Women Men
Right IMT 0.73 (0.15) 0.73 (0.16)
Left IMT 0.72 (0.14) 0.81 (0.22)
average IMT 0.72 (0.13) 0.77 (0.18)
Left plaque 31% 29%
Right plaque 38% 36%
Any plaque 51% 45%
Elevated IMT 18% 30%




Age 58.0 (8.1) 55.5 (7.9)
Total Cholesterol (mmol/l) 5.2 (1.3) 5.0 (1.9)
Systolic blood pressure (mmHg) 140.2 (21.7) 143.6 (17.9)
Current smokers 14% 14%
Former smokers 1.8% 3.3%
Family history 46% 38%
Waist circumference (cm) 96.6 (15.2) 104.1 (12.6)
BMI 31.9 (8.4) 32.5 (9.7)
HDL cholesterol (mmol/l) 1.7 (0.7) 1.3 (0.6)
LDL cholesterol (mmol/l) 2.9 (1.1) 2.8 (1.6)
Triglycerides 1.7 (1.5) 2.2 (2.4)
Less than recommended activity 41.3% 41.3%
Recommended activity 21.1% 19.6%
More than recommended 36.7% 32.6%
Individuals with diabetes 6.6% 12.2%
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group and subdivided by gender are shown in Table 1. Table 1 also
shows the proportions of the group in each risk category.
Fig. 1 shows the distribution of the carotid IMT (highest value of
right or left IMT) in the full group. Table 2 shows the mean right,
left, and average IMT values as well as the proportion with elevated
IMT (either left or right) and elevated IMT or carotid plaque visible.
Table 3 shows the CIMTmeasures in each risk category and the per-
centages of each risk category with elevated IMT. This is represented
graphically in Figs. 2 and 3, respectively.
Looking at the moderate risk group alone, 16.5% (95% CI: 9.8%–
23.2%) had elevated IMT meaning they were reclassiﬁed to a higher
risk group. This included 13.9% (95% CI: 5.7%–22.1%) of women and
20.4% (95% CI: 8.7% to 32.1%) of men in the moderate risk group
being reclassiﬁed.
Fig. 4 shows a scatterplot and linear regression of highest mea-
sured IMT versus estimated 10-year risk of fatal CVD calculated
using SCORE. This also provides a graphical representation of those
who are reclassiﬁed from the moderate (points shown in brown)










Fig. 1. Distribution of highest carotidDiscussion
In commonwith previous studies, it was shown here that a signif-
icant proportion of those identiﬁed as moderate risk by clinical risk
factors alone actually have signiﬁcant carotid atherosclerosis. This
reclassiﬁcation is particularly important in the moderate risk group
because it may signal the need for more intensive risk factor modiﬁ-
cation. This supports the recommendation in the European guide-
lines that assessment for carotid atherosclerosis be considered to
further risk stratify those at moderate risk (Perk et al., 2012). One
of the limitations of this study is that only cross-sectional data are
available. Therefore, although we have calculated the percentage of
individuals reclassiﬁed, we do not deﬁnitely know that these
reclassiﬁcations are uniformly in the correct direction. However, a
number of previous large prospective studies have shown that carot-
id atherosclerosis is related to the future development of CVD
(Chambless et al., 1997; Bots et al., 1997). In the Rotterdam study,
it was shown that in older women, the net reclassiﬁcation index for
the addition of CIMT to a model containing Framingham variables
was 8.0% (Elias-Smale et al., 2012).
The CIMT measurements were better correlated with guideline-
deﬁned risk category as opposed to SCORE. This is likely to be due
to the number of risk factor not included in the SCORE calculation,
most notably diabetes. It is interesting to note that based on the re-




CIMT measurements and percentage with elevated IMT or presence of plaque in each risk category (CI: conﬁdence interval).
Very high risk High risk Moderate risk
N Mean (95% CI) n Mean (95% CI) N Mean (95% CI) p for trend
Left IMT 24 0.84 (0.77–0.92) 43 0.82 (0.75–0.88) 121 0.71 (0.69–0.74) b0.001
Right IMT 24 0.80 (0.73–0.87) 43 0.73 (0.68–0.78) 120 0.71 (0.69–0.74) b0.001
Average IMT 24 0.82 (0.76–0.88) 43 0.77 (0.72–0.82) 121 0.71 (0.69–0.74) b0.001
Elevated IMT (%) 24 46 (24–67) 43 33 (18–0.47) 121 17 (10–0.23) b0.001
Carotid disease (%) 24 83 (67–99) 43 63 (48–78) 121 53 (44–62) b0.001
728 M. Cooney et al. / Preventive Medicine Reports 2 (2015) 725–7295% was associated with a CIMT of 0.9 mm, which has been deﬁned
by the European guidelines as the cut point for high risk (Perk
et al., 2012).
One of the advantages of using a risk estimation system that relies
only on conventional risk factors is the ease and speed of use, which fa-
cilitates implementation of risk assessment in routine clinical practice. A
system such as SCORE or HeartScore requires no additional risk factor
measurements and takes only seconds to calculate. Furthermore, sys-
tems have been developed to integrate these risk calculators with elec-
tronic health records providing an automatic estimation of CVD risk
(Wells et al., 2008).
The extra time required may be an obstacle to implementation of
assessment for carotid atherosclerosis in routine clinical practice.
The ease of use of the Cardiohealth station may assist with this.
The system can be operated by a technician with limited training
and in a signiﬁcantly shorter timeframe than when measured
using conventional ultrasonography. During this study, the mea-
surements could be made within a 30-min time period, and it
proved feasible to assess carotid measurements during a routine
outpatient clinic visit. Additionally, patients tolerated the proce-
dure without difﬁculty and many were interested in viewing and
discussing their results. Whether the measurement of carotid ath-
erosclerosis on the day of clinic would translate into increased suc-
cess with risk factor control deserves further study in the setting of
a study with longitudinal follow-up, ideally with participants
randomised to have the carotid assessment or usual care alone. It
is possible that the increased awareness of risk may encourage fa-
vorable lifestyle changes and improvements in adherence to
medication.
A validation study has evaluated the performance of this new
system in comparison to the conventional manual system for carot-
id scanning (Vanoli et al.). The comparative coefﬁcients of variation
for inter- and intra-operator variability were 8.2% and 6.4%,
respectively, for automated measurement and the inter-operatorFig. 2.Mean highest CIMT measurement in each risk category (mm).variability was 8.7% for manual measurement (Vanoli et al.).
There was no clinically relevant difference between measurements
obtained by the two systems (coefﬁcient of variation 4.6%) (Vanoli
et al.). The acquisition time of the automated system was signiﬁ-
cantly shorter than the conventional system (70 ± 32 vs. 121 ±
57 s, p b 0.01) (Vanoli et al.).
In conclusion, the Cardiohealth station provided a method for
the measurement of CIMT and detection of carotid plaque. The
ease of use of the system meant that the measurements could be
made as part of a routine clinic visit and the information relayed
to physician and patient immediately. This may aid risk factor mod-
iﬁcation. The carotid measurements correlated with risk category as
deﬁned in the European guidelines on CVD prevention. When risk
assessment for carotid atherosclerosis was incorporated into risk
assessment, 17% of those at moderate risk were reclassiﬁed.Conﬂict of interest
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Fig. 4. Scatterplot of the estimated 10-year fatal CVD risk and highest measured carotid IMT.
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